Publication | Closed Access

Results From VELOUR, a Phase 3 Study of Aflibercept (A) Versus Placebo (pbo) in Combination with FOLFIRI for the Treatment of Patients (pt) with Previously Treated Metastatic Colorectal Cancer (MCRC)

Gastrointestinal OncologyMedicineCancer ManagementPharmacologyColorectal CancerPharmacotherapyMolecular OncologyVersus PlaceboCancer TreatmentOncologyRadiation OncologyCancer ResearchPhase 3